Soleno Therapeutics Inc (SLNO)
R&D Expense Growth
17.95%
Quarterly · Period ending:
SLNO R&D Expense Growth
Latest reported17.95%period ending
Latest reported17.95%period ending
SLNO Quarterly R&D Growth (QoQ) (0.00% → 17.95%)
Latest values, visible window
High-resolution chart · PNG
SLNO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 17.9535% | |
| 13.718% | |
| -8.1119% | |
| -32.3297% | |
| -37.0893% | |
| -28.7079% | |
| 144.1906% | |
| -15.4773% | |
| 68.0516% | |
| 43.7862% | |
| 17.5452% | |
| -3.2919% | |
| 39.5276% | |
| 1.0342% | |
| 2.0292% | |
| -7.322% | |
| 6.8024% | |
| -24.839% | |
| -11.0793% | |
| -22.0128% | |
| 28.71% | |
| 15.3097% | |
| -20.9078% | |
| -8.8424% | |
| 26.9917% | |
| 17.4165% | |
| 19.8932% | |
| 35.6884% | |
| 25.9124% | |
| 4.7801% | |
| 22.0537% | |
| 45.2542% | |
| 15.3761% | |
| 4.1489% | |
| 0.8214% | |
| -2.0121% | |
| 4.2144% | |
| -15.6673% | |
| -14.7702% | |
| -25.1129% | |
| 37.98% | |
| 7.6483% | |
| 1.0161% | |
| 34.5103% | |
| 44.1197% | |
| -15.0326% | |
| 30.6011% | |
| 47.5592% | |
| 3.3966% | |
| -51.7004% | |
| 30.2596% | |
| -18.6344% | |
| 0% |